Portal de Periódicos da CAPES

The Prophylactic Use of Thio-Tepa in Transitional Cell Carcinoma of the Bladder

1966; Lippincott Williams & Wilkins; Volume: 96; Issue: 6 Linguagem: Inglês

10.1016/s0022-5347(17)63381-0

1527-3792

John W. Wescott,

Cancer Research and Treatments

No AccessJournal of Urology1 Dec 1966The Prophylactic Use of Thio-Tepa in Transitional Cell Carcinoma of the Bladder John W. Wescott John W. WescottJohn W. Wescott More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(17)63381-0AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail © 1966 by The American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsCited by Maeda H (1997) Pharmacological Uniqueness and Clinical Effects of Neocarzinostatin Neocarzinostatin, 10.1007/978-4-431-66914-2_11, (205-226), . Batts C (2016) Adjuvant Intravesical Therapy for Superficial Bladder CancerAnnals of Pharmacotherapy, 10.1177/106002809202601016, VOL. 26, NO. 10, (1270-1276), Online publication date: 1-Oct-1992. Richie J (1992) INTRAVESICAL CHEMOTHERAPYUrologic Clinics of North America, 10.1016/S0094-0143(21)00418-3, VOL. 19, NO. 3, (521-527), Online publication date: 1-Aug-1992. Fisher H (1987) Intravesical Chemotherapy for Bladder Tumors Cancer Chemotherapy by Infusion, 10.1007/978-94-009-3193-0_40, (538-559), . Flanigan R, Ellison M, Butler K, Gomella L and McRoberts J (2018) A Trial of Prophylactic Thiotepa or Mitomycin C Intravesical Therapy in Patients with Recurrent or Multiple Superficial Bladder CancersJournal of Urology, VOL. 136, NO. 1 Part 1, (35-37), Online publication date: 1-Jul-1986.Nissenkorn I, Servadio C, Vilikowski E and Glanz I (2018) Long-Term Intravesical Thiotepa Treatment in Patients With Superficial Bladder Tumors and Vesicoureteral RefluxJournal of Urology, VOL. 133, NO. 2, (198-199), Online publication date: 1-Feb-1985. Provinciali R (2018) I Risultati Degli Interventi ChirurgiciUrologia Journal, 10.1177/039156038405100109, VOL. 51, NO. 1, (39-48), Online publication date: 1-Feb-1984. Intini C (1984) Intravesical doxorubicin for the prophylaxis of superficial bladder tumors. A multicenter studyCancer, 10.1002/1097-0142(1984)54:4 3.0.CO;2-C, VOL. 54, NO. 4, (756-761), . Soloway M and Ford K (2018) Thiotepa-induced Myelosuppression: Review of 670 Bladder InstillationsJournal of Urology, VOL. 130, NO. 5, (889-891), Online publication date: 1-Nov-1983. Walzer Y, Matheny R, Blatnik A and Soloway M (1983) Urothelial trauma ? A mechanism of tumor promotion?World Journal of Urology, 10.1007/BF00326753, VOL. 1, NO. 2, (100-102), Online publication date: 1-Jun-1983. Jakse G, Hofst�dter F, Engelmann U and Jacobi G (1983) ABH-antigenicity of transitional cell carcinoma of the urinary bladder in patients subjected to topical chemoprophylaxisWorld Journal of Urology, 10.1007/BF00326748, VOL. 1, NO. 2, (82-85), Online publication date: 1-Jun-1983. Lum B (1983) Intravesical Chemotherapy of Superficial Bladder Cancer Urologic Cancer: Chemotherapeutic Principles and Management, 10.1007/978-3-642-81994-0_2, (3-36), . Agnelli G, Gresele P, de Cunto M and del Favero A (1982) Early onset life-threatening myelosuppression after low dose of intravesical thiotepaPostgraduate Medical Journal, 10.1136/pgmj.58.680.380, VOL. 58, NO. 680, (380-381), Online publication date: 1-Jun-1982. Prout G and Hagen I (1982) Chemotherapy of Superficial Bladder Carcinoma Genitourinary Cancer 1, 10.1007/978-94-009-7436-4_6, (143-167), . Schulman C (1982) Intravesical Chemotherapy for Superficial Bladder Tumors Clinical Bladder Cancer, 10.1007/978-1-4613-3353-1_13, (101-111), . ENGLAND H, FLYNN J, PARIS A and BLANDY J (1981) Early Multiple-dose Adjuvant Thiotepa in the Control of Multiple and Rapid TI Tumour NeogenesisBritish Journal of Urology, 10.1111/j.1464-410X.1981.tb03267.x, VOL. 53, NO. 6, (588-592), Online publication date: 1-Dec-1981. Jakse G, Bauer H, Wieland W and Jacobi G (1981) Rezidivprophylaxe durch intravesikale Instillationen mit Adriamycin, Mitomycin-C oder VM-26 beim pTA-1 Blasenkarzinom Verhandlungsbericht der Deutschen Gesellschaft für Urologie, 10.1007/978-3-642-81706-9_99, (351-352), . Soloway M and Masters S (1980) Urothelial susceptibility to tumor cell implantation influence of cauterizationCancer, 10.1002/1097-0142(19800901)46:5 3.0.CO;2-E, VOL. 46, NO. 5, (1158-1163), Online publication date: 1-Sep-1980. Soloway M (2018) Rationale for Intensive Intravesical Chemotherapy for Superficial Bladder CancerJournal of Urology, VOL. 123, NO. 4, (461-466), Online publication date: 1-Apr-1980. SOLOWAY M (2018) The Management of Superficial Bladder CancerCancer, 10.1002/cncr.1980.45.s7.1856, VOL. 45, (1856-1865), Online publication date: 1-Apr-1980. Murphy W and Soloway M (1980) The effect of thio-TEPA on developing and established mammalian bladder tumorsCancer, 10.1002/1097-0142(19800301)45:5 3.0.CO;2-H, VOL. 45, NO. 5, (870-875), Online publication date: 1-Mar-1980. Sakamoto S, Ogata J, Ikegami K and Maeda H (1980) Chemotherapy for bladder cancer with neocarzinostatin: Evaluation of systemic administrationEuropean Journal of Cancer (1965), 10.1016/0014-2964(80)90115-2, VOL. 16, NO. 1, (103-113), Online publication date: 1-Jan-1980. Schulman C (1980) Adjuvant Therapy of T1 Bladder Carcinoma : Preliminary Results of an EORTC Randomised Study Bladder Tumors and other Topics in Urological Oncology, 10.1007/978-1-4613-3030-1_71, (347-354), . Nocks B, Nieh P and Prout G (2018) A Longitudinal Study of Patients with Superficial Bladder Carcinoma Successfully Treated with Weekly Intravesical Thio-TEPAJournal of Urology, VOL. 122, NO. 1, (27-29), Online publication date: 1-Jul-1979. Csellár M and Csontai Á (1979) Local application of THIO-TEPA in the prevention of recurrent papillary carcinoma of the bladderInternational Urology and Nephrology, 10.1007/BF02082809, VOL. 11, NO. 1, (39-44), Online publication date: 1-Mar-1979. Schulman C, Sylvester R, Robinson M, Smith P, Lachand A, Denis L, Pavone-Macaluso M, De Pauw M and Staquet M (1979) Adjuvant Therapy of T1 Bladder Carcinoma: Preliminary Results of an EORTC Randomized Study Adjuvant Therapies and Markers of Post-Surgical Minimal Residual Disease II, 10.1007/978-3-642-81332-0_51, (338-345), . Gavrell G, Lewis R, Meehan W and Leblanc G (2018) Intravesical Thio-tepa in the Immediate Postoperative Period in Patients with Recurrent Transitional Cell Carcinoma of the BladderJournal of Urology, VOL. 120, NO. 4, (410-411), Online publication date: 1-Oct-1978.Nakazono M and Iwata S (2018) A Preliminary Study of Chemotherapeutic Treatment for Bladder TumorsJournal of Urology, VOL. 119, NO. 5, (598-600), Online publication date: 1-May-1978.Nieh P, Daly J, Heaney J, Heney N and Prout G (2018) The Effect of Intravesical Thio-tepa on Normal and Tumor UrotheliumJournal of Urology, VOL. 119, NO. 1, (59-61), Online publication date: 1-Jan-1978. Loening S (1978) Die onkologische Therapie des Harnblasenkarzinoms 29. Tagung vom 21. September bis 24. September 1977 in Stuttgart, 10.1007/978-3-642-81222-4_6, (26-34), . Dobrzecki W and Kaczmarek A (1977) The prophylactic use of Thio-TEPA, an adjuvant in the treatment of bladder tumoursInternational Urology and Nephrology, 10.1007/BF02082016, VOL. 9, NO. 2, (145-149), Online publication date: 1-Jun-1977. Lunglmayr G (1977) Resorption von Proteasen und Amylasen bei Geschwulstbefall der HarnblaseEuropean Surgery, 10.1007/BF02601089, VOL. 9, NO. 1, (11-14), Online publication date: 1-Jan-1977. BURNAND K, BOYD P, MAYO M, SHUTTLEWORTH K and LLOYD-DAVIES R (1976) Single Dose Intravesical Thiotepa as an Adjuvant to Cystodiathermy in the Treatment of Transitional Cell Bladder CarcinomaBritish Journal of Urology, 10.1111/j.1464-410X.1976.tb02742.x, VOL. 48, NO. 1, (55-59), Online publication date: 1-Feb-1976. Soloway M and Martino C (1976) Prophylaxis of bladder tumor implantation Intravesical and systemic chemotherapyUrology, 10.1016/0090-4295(76)90557-4, VOL. 7, NO. 1, (29-34), Online publication date: 1-Jan-1976. Hisazumi H, Uchibayashi T, Naito K, Misaki T and Miyazaki K (2018) The Prophylactic Use of Thio-Tepa and Urokinase in Transitional Cell Carcinoma of the Bladder: A Preliminary ReportJournal of Urology, VOL. 114, NO. 3, (394-398), Online publication date: 1-Sep-1975.Mishina T, Oda K, Murata S, Ooe H, Mori Y and Takahashi T (2018) Mitomycin C Bladder Instillation Therapy for Bladder TumorsJournal of Urology, VOL. 114, NO. 2, (217-219), Online publication date: 1-Aug-1975. Veenema R, Romas N and Fingerhut B (1974) Chemotherapy for bladder cancerUrology, 10.1016/S0090-4295(74)80001-4, VOL. 3, NO. 2, (135-139), Online publication date: 1-Feb-1974. Lunglmayr G, Czech K, Zekert F and Kellner G (1973) Bladder hyperthrmia in the treatment of vesical papillomatosisInternational Urology and Nephrology, 10.1007/BF02081753, VOL. 5, NO. 1, (75-84), Online publication date: 1-Mar-1973. Oravisto K (2009) Optimal Intravesical Dosage of Thio-Tepa in the Prophylaxis of Recurrent Bladder PapillomatosisScandinavian Journal of Urology and Nephrology, 10.3109/00365597209132075, VOL. 6, NO. 1, (26-28), Online publication date: 1-Jan-1972. Lunglmayr G and Czech K (2018) Absorption Studies on Intraluminal Thio-Tepa for Topical Cytostatic Treatment of Low-Stage Bladder TumorsJournal of Urology, VOL. 106, NO. 1, (72-74), Online publication date: 1-Jul-1971. Mitchell R (2008) INTRAVESICAL THIOTEPA IN THE TREATMENT OF TRANSITIONAL CELL BLADDER CARCINOMABritish Journal of Urology, 10.1111/j.1464-410X.1971.tb12024.x, VOL. 43, NO. 2, (185-188) Watne A (1970) Solid tumor chemotherapyThe American Journal of Surgery, 10.1016/0002-9610(70)90052-8, VOL. 119, NO. 3, (279-287), Online publication date: 1-Mar-1970. Yeenema R, Dean A, Uson A, Roberts M and Longo F (2018) Thiotepa Bladder Instillations: Therapy and Prophylaxis for Superficial Bladder TumorsJournal of Urology, VOL. 101, NO. 5, (711-715), Online publication date: 1-May-1969.Crassweller P, Ley D and Ranking G (2018) The Use of Nitrogen Mustard for Prevention of Bladder Tumor RecurrenceJournal of Urology, VOL. 100, NO. 1, (21-23), Online publication date: 1-Jul-1968. Volume 96Issue 6December 1966Page: 913-918 Advertisement Copyright & Permissions© 1966 by The American Urological Association Education and Research, Inc.MetricsAuthor Information John W. Wescott More articles by this author Expand All Advertisement PDF downloadLoading ...